Side by side, stride by stride, let’s pick up the pace of progress

Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma

Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT

Chartered Clinical Psychologist, Dr Nick Mooney, offers advice on how best to start talking with your family and friends about brain tumours.

New research from one of our funded grants gives much needed insight into group 3 and 4 medulloblastoma

There have been a number of headlines over the last two days about a ‘new treatment’ that may save thousands of lives for brain tumour patients

A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)

In preparation for Mental Health Awareness Week 2019, we’ve pulled together six top tips for looking after your mental health that are perfect for anybody affected by a brain tumour.

This weekend marks a year since Tessa Jowell died from a brain tumour

The Brain Tumour Charity held the first ever roundtable on brain tumours in Wales, bringing together a wide range of stakeholders within the brain tumour community to discuss what needs to be achieved to improve patient outcomes in Wales.

Research presented recently at a conference in Milan showed that a particular type of radiation therapy could help spare children’s memory and thinking when they undergo treatment for brain tumours

Matt is the son of Baroness Tessa Jowell, who galvanised the political community in the House of Lords with her campaign for those affected by brain tumours following her own diagnosis

A research team from Germany has used artificial intelligence to improve the assessment of treatment response in brain tumours

NHS England are currently running a questionnaire to find out more about people’s experiences of Personal Health Budgets, which could feed into and shape the future of personalised healthcare

The Charity’s corporate partnerships officer Steve Salazar, has been pounding the training miles

Exams are challenging at the best of times. But if you’re living with a brain tumour, you’re also likely to be struggling with fatigue, concentration or memory problems, making them even more difficult.

Oliver Highway was first diagnosed with a brain tumour in April 2012, aged just 39. As a result of his tumour and its treatment, Oliver’s life was turned upside-down when he was left with speech and cognition problems. But with the help of his family, Oliver hasn’t let these side-effects hold him back.

We’re thrilled to be the first ever UK charity to partner with the US-based Center for Advancing Innovation (CAI), an organisation dubbed ‘Tinder for start-ups’. We’ll be co-funding a pioneering initiative coordinated by the CAI, called The Brain Race. This will ask researchers and inventors from across the world to submit innovative ideas aimed at defeating brain tumours.

We are delighted to announce that M&C Saatchi has chosen The Brain Tumour Charity as its charity of the year for 2019

Now, with only one year to go, we‘re looking back at some of the outstanding things you’ve helped us achieve since 2015. And we’re looking forward, to our plans to push for more progress in the next 12 months.

A recent study highlights gaps in neuro-onoclogy services provided nationally

Tom opens up about why he supports us and raising awareness during Brain Tumour Awareness Month

Interviewed by our Young Ambassador, Grace Latter, Hal Cruttenden opens up about his mum’s diagnosis and why he supports the work we do

Further research needed to identify possible warning signs of a brain tumouriple subtle ‘changes’ and visit their GP at least once before being diagnosed with a brain tumour